Saxagliptin Market Anticipated To Grow At A Significant Pace By 2022

Diabetes is the chronic condition associated with abnormally high level of glucose in the blood. Insufficient or non production of insulin in pancreas causes diabetes. Globally, the incidence of diabetes is increasing significantly and it is becoming a major burden. According to World Health Organization (WHO), approximately 221 million people are suffering from diabetes. There are large numbers of blood glucose lowering drugs. Saxagliptin is an oral anti-diabetic agent known as DPP IV inhibitor. DDP IV inhibitor is an enzyme helps in suppressing the release of glucagon. Saxagliptin is used for medication of diabetes, as to boost the amount of insulin in the body produced after meal. Saxagliptin is marketed under the brand name Onglyza. Saxagliptin acts on natural hormone in the body known as incretins. Saxagliptin has various side effects such as headache, urinary tract infection, upper respiratory tract infection and nasopharyngitis. Saxagliptin can also cause complications such as stroke and heart attack.

For detailed insights on enhancing your product footprint, request for a Sample here @  https://www.persistencemarketresearch.com/samples/3399

North America and Europe dominates the global market for saxagliptin due to large number of aging population and increasing prevalence of type II diabetes. Asia is expected to show high growth rates in the next five years in the global saxagliptin market. China and India are expected to be the fastest growing saxagliptin markets in Asia-Pacific region. Some of the key driving forces for saxagliptin market in emerging countries are large pool of patients, increasing healthcare expenditure and rising government funding.

In recent times there is increased use of saxagliptin due to increasing incidence of type II diabetes. Increasing prevalence of obesity, increasing sedentary lifestyle and junk food habits and increased government funding are some of the key factors driving the growth for global saxagliptin market. In addition, increasing healthcare awareness is also fuelling the growth of global saxagliptin market. However, strict regulations for approval of drugs and substitutes for treatment of diabetes are some of the major factors restraining the growth for global saxagliptin market.

To receive extensive list of important regions, ask for TOC here @ https://www.persistencemarketresearch.com/toc/3399

Pipeline drugs with saxagliptin would develop opportunity for the growth of the global saxagliptin market. However, side effects of saxagliptin would pose a challenge for the global saxagliptin market. Some of the major companies operating in the global saxagliptin market are Bristol-Myers Squibb Company and AstraZeneca.

Lab On Chips Application Market Higher Mortality Rates By 2022

Lab-on-chips is changing the field of diagnosis. Lab-on-chips is an integrated miniaturized device used to perform laboratory operations on a single micro-process chip in small scale. Lab-on-chip is also known as micro-total analytical system. Lab-on-chips combine microfluidics and microelectronics on a single chip to perform complex tests. Lab-on-chip has its main application in biotechnological and medical applications. Lab-on-chip is used in the application of microfluidic-chip-based technologies such as medical diagnostics, chemical synthesis and the study of complex cellular process. Lab-on-chips helps in providing quick diagnosis.

North America dominates the global market for lab-on-chips application due to large number of aging population. Asia followed by the Europe are expected to show high growth rates in the next five years in global lab-on-chips application market. China and India are expected to be the fastest growing lab-on-chips application markets in Asia-Pacific region. Some of the key driving forces for lab-on-chips application market in emerging countries are increasing R&D investment, large pool of patients and rising government funding.

For detailed insights on enhancing your product footprint, request for a Sample here @  https://www.persistencemarketresearch.com/samples/3396

In recent times there is increased use of lab-on-chips application due to increasing point of care testing. Rise in personalized medicine, drug discovery and life science research, need for high speed diagnostics and increased government funding are some of the key factors driving the growth for the global lab-on-chips application market. In addition, increasing healthcare awareness and miniaturization reduce the cost of testing are also fuelling the growth of the global lab-on-chips application market. However, limited technical knowledge related to lab-on-chips and availability of alternative technologies are some of the major factors restraining the growth for the global lab-on-chips application market.

To receive extensive list of important regions, ask for TOC here @ https://www.persistencemarketresearch.com/toc/3396

Increasing R&D investment would lead to growth in lab-on-chips application market in Asia. In addition, broaden application of lab-on-chips would develop opportunity for the global lab-on-chips application market. However, high cost involved in manufacturing of lab-on-chip could lead a challenge for the global lab-on-chips application market. The trends for the global lab-on-chips application market are next generation technology for lab-on-chip such as lab on CD-ROM and EFAD chip technology. Some of the major companies operating in the global lab-on-chips application market are

• EMD Millipore
• Life Technologies Corporation
• Abbott Laboratories
• Roche Diagnostics
• Siemens Healthcare
• Bio-Rad Laboratories.

Private Healthcare Market Registering A Strong Growth By 2022

Private healthcare is referred as privately funded healthcare facility. Private healthcare has various sectors such as acute medical care, private medical insurance, long term care, psychiatric care and primary care. Private healthcare is funded by private medical insurance policies and by out of pocket expenditure. Long term care healthcare sector is the largest sector in the private healthcare market. The private healthcare sector varies with size and responsibilities in various countries. In many countries, private healthcare sector is extremely fragmented. Private healthcare sector has many small practices owned by healthcare professionals. In addition, private healthcare sector is becoming corporate.

North America dominates the global market for private healthcare due to large number of aging population and increasing lifestyle associated diseases. Asia followed by the Europe are expected to show high growth rates in the next five years in the global private healthcare market. China and India are expected to be the fastest growing private healthcare markets in Asia-Pacific region. Some of the key driving forces for private healthcare market in emerging countries are large pool of patients, increasing healthcare awareness and increasing healthcare expenditure. In addition, in the emerging countries due to lack of resources the government is not able to meet healthcare needs.

For detailed insights on enhancing your product footprint, request for a Sample here @  https://www.persistencemarketresearch.com/samples/3393

In recent times there is increased use of private healthcare due to increasing demand of healthcare services. Increasing geriatric population, improved reimbursement policies and increasing incidence of chronic diseases are some of the key factors driving the growth for the global private healthcare market. In addition, high amount of National Health Services (NHS) outsourcing and emergence of advance medical technologies and treatment are also fuelling the growth of the global private healthcare market. However, high cost involvement and economic slowdown are some of the major factors restraining the growth for global private healthcare market.

To receive extensive list of important regions, ask for TOC here @ https://www.persistencemarketresearch.com/toc/3393

Increasing medical tourism and less waiting time for treatments would develop opportunity for the global private healthcare market. The trend for the global private healthcare market is increasing demand for diagnostic treatment and care.

Some of the major companies operating in the global private healthcare market are:

• Bupa Care Homes Plc
• Bupa Insurance Ltd.
• Capita Health and Wellbeing Ltd.
• Four Seasons Healthcare Ltd.
• Colombia Asia
• MedLife
• Hca International.

North American Hospital Laundry Boilers Market To Gain A Stronghold By 2022

Laundry and boilers services play an important role in sterilization and maintains contamination free environment in hospitals. Laundry service is responsible for delivery of adequate amount of clean and sterile linen to patients and healthcare professionals. The major tasks of laundry service include collection of linen, washing, drying and delivery to users. Boilers are used for steam and hot waters for vital needs, such as space heating and sterilization of linen and provide hygienic conditions for patients.

The U.S. and Canada dominates the North American hospital and laundry boilers market due to improved healthcare infrastructure in the region. For instance, in 2012, American Hospital Association (AHA), a national organization that represents and serves all types of hospitals and healthcare networks conducted an annual survey of total number of registered hospitals in the U.S. This number was 5,723 in 2012. Registered hospitals are those hospitals that fulfill all the AHA criteria. This improved healthcare system in the U.S. has resulted in significant rise in demand of laundry and boiler services to main hygienic conditions for the patients and healthcare professionals.

For detailed insights on enhancing your product footprint, request for a Sample here @  https://www.persistencemarketresearch.com/samples/3389

In recent time, rising number of hospital admissions is key driver for the North American hospital and laundry boilers market. For instance, in 2010, according to Centers for Disease Control and Prevention (CDC), about 2, 58,000 hospital admissions had registered for hip fractures among people aged 65 and above and the number is expected to reach 2, 89, 000 by 2030. This increasing number of hospital admissions requires sterile linen for their better comfort in hospitals. However, the high energy cost to operate boilers in hospitals is key restraint for the North American hospital and laundry boilers market. In addition, strict regulation associated with the generation of steam through boilers also obstructs growth of the North American Hospital and laundry boilers market. For instance, hospitals require accreditation from Joint Commission on the Accreditation of Healthcare Organizations (JCAHO) for steam generation.

To receive extensive list of important regions, ask for TOC here @ https://www.persistencemarketresearch.com/toc/3389

Some of the major companies operating in the North American hospital and laundry boilers market are:

• Parker Boiler Co.
• Indeck Power Equipment Co.
• Fulton
• Powerhouse Equipment & Engineering Co.
• Smith Hughes Co.
• Nationwide Boiler
• Energy Equipment Co.
• Reagan-Riter Boiler Works
• Energy Products Co..

Decontamination Equipment Market Gain Impetus Due To The Growing Demand Over Forecast To 2022

Decontamination refers to a process of neutralization or removal of chemical agents, infectious microorganisms and radioactive materials. Decontamination equipment refer to the equipment such as a chamber or an isolated box in which decontamination process is performed.  Decontamination equipment market has been growing at a fast rate due to increase in awareness of such processes and governments of various countries taking initiatives in this field. Decontamination may be done by physical means, chemicals or biology based methods. Decontaminating with physical means, involves techniques such as thermal, high pressure methods and others. Decontamination by chemicals involves use of oxidizing agents, surfactants for neutralization of chemical waste and others. Biology based decontamination methods involve use of enzymatic systems, artificial bacteria and others. Growing concern for hospital acquired infections and increase in aged population that are more prone to diseases are driving the global decontamination equipment market.

For detailed insights on enhancing your product footprint, request for a Sample here @  https://www.persistencemarketresearch.com/samples/3368

North America, followed by Europe, dominates the global market decontamination equipment due to large number of aging population and broad technical applications decontamination equipment in the region. Asia is expected to show high growth rates in the next few years in decontamination equipment market. China and India are expected to be the fastest growing decontamination equipment markets in Asian region. Some of the key driving forces for decontamination equipment market in emerging countries are increasing R&D investment, growing awareness about the consequences of contamination and rising government initiatives in these countries.

Some of the major factors that are driving the global decontamination equipment market are rise in the prevalence of infection cases, government initiatives in the field, technological advancement and growing awareness for various types of decontamination procedures. However, stringent government regulations in some countries, high cost of the equipment and economic slowdown are some of the major factors that are restraining global decontamination equipment market. In addition, lengthy lifecycles of decontamination equipments is restraining the decontamination equipment market.

To receive extensive list of important regions, ask for TOC here @ https://www.persistencemarketresearch.com/toc/3368

Emerging countries hold a great potential for decontamination equipment market. Innovation of decontamination equipment with improved contamination standards is expected to offer good opportunity for global decontamination equipment market. Long time required for complete decontamination and big size of equipment are some of the major challenges faced by global decontamination equipment market. Some of the major companies dealing in decontamination equipment market are

• STERIS Corporation
• Getinge Group
• Noxilizer
• Cosmed Group
• Sterigenics International
• Stericert

Oncology Drugs Market Likely To Emerge Over A Forecast To 2022

Oncology is a branch of study and treatment of cancer. Cancer is disease in which abnormal cells grow and divide without control. Oncology drugs help in diagnosis cancer. Some of the causes of cancer are tobacco and smoking, viral infections, genetic causes, carcinogens, bacterial infections, physical activities, eating habits and age. Various types of cancer that can be treated by oncology drugs are blood cancer, endocrine cancer, lung cancer, bone cancer, skin cancer, genitourinary cancer, gastrointestinal cancer, breast cancer, eye cancer, head and neck cancers and gynaecologic cancer. On the basis of treatment, oncology drugs market can be segmented into chemotherapy, immunotherapy, surgery, radiation therapy, stem cell transplant, hormone therapy and others.

North America, followed by Europe, has the largest market for oncology drugs due to new drug development, government initiatives and developed healthcare infrastructure in this region. Asia is expected to show high growth rate in the oncology drugs market in next few years due to increasing incidence of cancer cases, rise in the use of tobacco products and growth in aging population in the region.

For detailed insights on enhancing your product footprint, request for a Sample here @  https://www.persistencemarketresearch.com/samples/3312

Technological advancement, increasing incidence of various type of cancers, rise in need for R&D activities in cancer and growing concerns over high death rates due to cancer are driving the market for oncology drugs. In addition, introduction of new drugs and therapies for cancer and government support to improve healthcare condition are expected to drive the market for oncology drugs. However, high cost of cancer treatments, strict government regulations, huge investment involvement in the development and clinical trials of the therapies and side effects of cancer treatments are some of the major factors restraining the growth for global oncology drugs market.

To receive extensive list of important regions, ask for TOC here @ https://www.persistencemarketresearch.com/toc/3312

Growing demographics and economies in the developing countries such as China and India are expected to offer good opportunities in oncology drugs market in Asia. In addition, new innovations in cancer drugs and therapies and rise in awareness about the new drugs and therapies available in the market are expected to offer new opportunities for global oncology drugs market. Personalized medicines, increasing number of mergers and acquisitions, new product launches and rise in number of collaborations and partnerships are some of the trends that have been observed in global oncology drugs market. Some of the major companies operating in the global oncology drugs market are

• Amgen
• Bayer Healthcare AG
• CELGENE CORPORATION
• GlaxoSmithKline
• ARIAD Pharmaceuticals
• Eli Lilly and Company
• Novartis
• Hoffmann-La Roche Ltd.
• AstraZeneca
• Boehringer Ingelheim GmbH

 

---

Molecular Diagnostics Market Will Reflect Significant Growth Prospects During 2015 – 2021

In-vitro diagnostics is a method of performing a diagnostic test to detect disease, condition or infection in an artificial environment. Molecular diagnostic is one of the major segments of in-vitro diagnostics market. Molecular diagnostics is used to measure and detect the presence of genetic material associated with specific disease. It is used to identify DNA and RNA at molecular level. Molecular diagnostics is a tool to improve clinical outcomes and medical decisions. Molecular diagnostic includes all tests used to identify a disease, by analyzing molecules such as DNA, protein or RNA in a fluid or tissue. Nowadays molecular diagnostics is used in early detection of infectious diseases, cancer and genetic disorder, by using molecular and genetic technologies. Molecular diagnostics is also used in detection of abnormalities in pre-natal stage. In addition, molecular diagnostic kits are used in pharmacogenetics testing and blood donor screening.

For detailed insights on enhancing your product footprint, request for a Sample here @  https://www.persistencemarketresearch.com/samples/2784

North America dominates the global market of molecular diagnostics due to increasing incidence of infectious diseases and lifestyle associated diseases. In addition, innovations in molecular diagnostics for treating cancer, government support for research and development, and high patient awareness levels are driving the growth of molecular diagnostic market in North America. Asia is expected to show high growth rates in the next five years in molecular diagnostics market. Some of the factors driving growth of molecular diagnostics in emerging markets are increasing demand of genetic tests, advancement in healthcare infrastructure and large patient pool in countries such as India and China.

In recent times there is increased use of molecular diagnostics due to increasing application in blood screening, genetic disorders and cancer. Increasing prevalence of chronic and infectious diseases such as HIV and hepatitis, rising awareness and acceptance of personalized medicine and companion diagnostics are also fueling growth in the global molecular diagnostics market. However, changing reimbursement regulations and delayed approval of many new molecular diagnostic tests are some of the factors inhibiting the growth for global molecular diagnostics market.

To receive extensive list of important regions, ask for TOC here @ https://www.persistencemarketresearch.com/toc/2784

Growing demand for genetic tests is an opportunity for global molecular diagnostics market. However, strict regulatory framework and lack of skilled labor are some of the major challenges for global molecular diagnostics market. Some of the major companies operating in global molecular diagnostics market are

• Novartis AG
• Roche Diagnostics
• QIAGEN
• Siemens Healthcare
• Abbott Laboratories
• Gen-Probe
• (Hologic Inc.)
• Cepheid
• Beckman Coulter
• Becton
• Dickinson & Company
• Myriad Genetics

Read more details about healthcare sector growth reports check here @ https://medium.com/@healthnewslive

Intraocular Lens Market Prophesied To Grow At A Faster Pace By 2022

Cataract is the clouding of the eye lens. Cataract is the leading cause of blindness worldwide. Intraocular lens is a synthetic artificial lens placed to replace natural lens. Intraocular lenses are used for the surgical treatment of cataract. According to the World Health Organization (WHO), in 2010, approximately 20 million cataract surgeries were performed and are expected to reach approximately 32 million by 2020. Several types of intraocular lenses implants are available to improve vision. Monofocal intraocular lenses are best choice for limited budget. Whereas, premium intraocular lenses are specifically designed to reduce patients need for glasses. Tronic intraocular lenses, multifocal intraocular lenses and accommodating intraocular lenses are some of the premium intraocular lenses.

North America dominates the global market for intraocular lens due to large number of aging population and availability of reimbursements. Asia is expected to show high growth rates in the next five years in the global intraocular lens market. China and India are expected to be the fastest growing intraocular lens markets in Asia-Pacific region. Some of the key driving forces for intraocular lens market in emerging countries are large pool of patients and rising government funding.

For detailed insights on enhancing your product footprint, request for a Sample here @  https://www.persistencemarketresearch.com/samples/3290

In recent times there is increased use of intraocular lens due to increasing prevalence of cataract in aging population. Rise in adoption of premium intraocular lens such as accommodating intraocular lens and multifocal intraocular lens and increasing government initiatives are some of the key factors driving the growth for global intraocular lens market. In addition, increasing healthcare awareness is also fuelling the growth of global intraocular lens market. However, high cost related with surgical procedure and post-operative complications such as refractive errors are some of the major factors restraining the growth for global intraocular lens market.

To receive extensive list of important regions, ask for TOC here @ https://www.persistencemarketresearch.com/toc/3290

Availability of advance technologies such as micro-incision cataract surgery and femtosecond lasers would develop opportunities for global intraocular lens market. The trend for global intraocular lens market is multi-distance vision capabilities.

Some of the major companies operating in the global intraocular lens market are:

• Alcon
• Abbott Medical Optics
• Bausch & Lomb Incorporated
• Carl Zeiss Meditec AG
• Rayner Intraocular Lenses Limited
• Eyekon Medical
• Lenstec
• HumanOptics AG
• STAAR Surgical Company
• Hoya Corporation.

Biomedical Materials Market Detailed Analytical Overview By 2022

Medical devices and material market is growing at a significant rate due to increase in the prevalence of diseases and growing government incentives in healthcare sector. Biomedical materials refer to the materials that are used in manufacturing of medical devices used in healthcare sector. A biomedical material may be natural or synthetic in nature, and is used to replace or treat the tissue or organ to support its proper working. Various biomedical materials that are available in the market include silicone hydrogels, biostable polyurethanes, polymer stabilizing technology, resorbable materials, hydrophilic and non-biofouling coatings and ultra-high-molecular-weight polyethylene (UHMWPE) fibres.

North America dominates the global market for biomedical materials due to large number of aging population and broad technical applications of biomedical materials in the region. Europe, followed by Asia, is expected to experience high growth rate in the next few years in global biomedical materials market. China and India are expected to be the fastest growing biomedical materials markets in Asian region. Some of the key driving forces for biomedical materials market in emerging countries are increasing R&D investment, large pool of patients and rising government funding.

For detailed insights on enhancing your product footprint, request for a Sample here @  https://www.persistencemarketresearch.com/samples/3273

Aging population, increasing prevalence of chronic diseases and growing awareness for availability of different types of biomaterials has been driving the global biomedical materials market.  In addition, improvement in healthcare facilities and technological advancement has been driving the biomedical materials market. However, high cost involved and lack of experienced professionals has been restraining the global biomedical materials market.

To receive extensive list of important regions, ask for TOC here @ https://www.persistencemarketresearch.com/toc/3273

Emerging markets hold a great potential for growth of biomedical materials market. Innovation of some new products with better efficacy is expected to offer good opportunity for biomedical materials market. Side effects such as burning sensation and others are a challenge for biomedical materials market. Some of the latest trends that have been observed in the biomedical materials market include growing popularity of bioabsorbable materials and companies involved in partnerships and collaborations. In addition, companies have been involved in R&D of new products.

Some of the major companies dealing in global biomedical materials market include:

• Johnson & Johnson
• 3M Healthcare
• DSM Biomedical
• Biomet
• Smith & Nephew.
• RTI Biologics
• Wright Medical
• Zimmer
• Tornier.

Protein Expression Market To Hold A High Potential For Growth By 2022

Protein expression is a technique in which proteins are synthesized, modified and regulated in living organism. Protein expression is used to study for the presence of one or more proteins in the cell or tissue. Protein expression is used by pharmaceutical companies, biotechnology companies, academic research institutes, contract research organizations and others for proteomics. On the basis of expression systems, protein expression market can be segmented into insect cell expression systems, prokaryotic expression systems, mammalian cell expression systems, yeast expression systems and other expression systems.  On the basis of application, protein expression market can be segmented into industrial proteins, therapeutic proteins and research applications. On the basis of products, protein expression market can be classified into expression vectors, reagents, competent cells, instruments and services. Protein expression is used in manufacturing of commercial proteins which are used in pharmaceutical and biotechnology companies.

For detailed insights on enhancing your product footprint, request for a Sample here @  https://www.persistencemarketresearch.com/samples/3254

North America, followed by Europe, has the largest market for protein expression due to high investments in research and development activities and increasing involvement of pharmaceuticals and biotechnology companies in the protein expression market in this region. Asia is expected to show high growth rate in the protein expression market in next few years due to rise in research and development expenditure in the region.

Rapid growth in biologics and proteomics market, low productivity of R&D in pharmaceuticals and biotechnology companies, increasing research activities in the pharmaceutical sector and rise in the demand of therapeutic proteins are expected to drive the market for protein expression. However, low expenditure in research and development and high cost of proteomics research are some of the factors restraining the growth for global protein expression market.

To receive extensive list of important regions, ask for TOC here @ https://www.persistencemarketresearch.com/toc/3254

Growing demographics and economies in the developing countries such as India and China is expected to lead the growth in protein expression market. In addition, technological advancement in proteomics and novel product development for protein expression are expected to offer new opportunities for global protein expression market. Increasing number of mergers and acquisitions and new product launches are some of the latest trends that have been observed in global protein expression market. Some of the major companies operating in the global protein expression market are

• Agilent Technologies
• Sigma-Aldrich Corporation
• Life Technologies Corporation
• Bio-Rad Laboratories
• Takara Bio
• Promega Corporation
• Merck Millipore
• QIAGEN

Viral Molecular Diagnostics Market Prevalent Opportunities Up To Forecast To 2022

Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease. Viral molecular diagnostic helps in diagnosis of infectious diseases caused by virus. Viral molecular diagnostics has varied applications in hospitals, academics institutions, laboratories and others. On the basis of application, viral molecular diagnostics can be segmented into infectious diseases, genetics, blood screening, microbiology and others. On the basis of infectious diseases, viral molecular diagnostics market can be segmented into hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV) human papillomavirus (HPV) and others. On the basis of technology, viral molecular diagnostics market can be segmented into polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), microarrays, in situ hybridization and others.

North America, followed by Europe, has the largest market for viral molecular diagnostics due to developed healthcare infrastructure, accessibility and affordability of diagnostic tests for viral infectious diseases in this region. Asia is expected to show high growth rate in the viral molecular diagnostics market in next few years due to high incidence of viral infectious diseases and rise in awareness about treatments and disease diagnosis in the region.

For detailed insights on enhancing your product footprint, request for a Sample here @  https://www.persistencemarketresearch.com/samples/3251

Increasing demand for advanced molecular diagnostic tests, rise in the incidence for viral infection diseases, technological advancement in molecular diagnostics are expected to drive the market for viral molecular diagnostics. In addition, rise in awareness about viral infections and available diagnostic tests for viral infectious diseases are expected to drive the market for viral molecular diagnostics. However, lack of skilled professionals and high cost of molecular diagnostics are some of the major factors restraining the growth for global viral molecular diagnostics market.

To receive extensive list of important regions, ask for TOC here @ https://www.persistencemarketresearch.com/toc/3251

Growing demographics and economies in the developing countries such as India and China is expected to lead the growth in viral molecular diagnostics market. In addition, innovations and development of advanced molecular diagnostic tests for viral infections and increasing awareness about the infectious diseases and diseases diagnosis are expected to offer new opportunities for global viral molecular diagnostics market. Increasing number of collaborations and partnerships and new product launches are some of the latest trends that have been observed in global viral molecular diagnostics market. Some of the major companies operating in the global viral molecular diagnostics market are

• Abbott Laboraories
• Bio-Rad Laboratories
• Becton
• Dickinson and Company
• Hoffmann-La Roche Ltd
• Roche Diagnostics
• Qiagen
• Olympus Corporation
• Thermo Fisher Scientific
• Gen-Probe